BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25496149)

  • 1. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
    Meredith AJ; Slotty A; Matzke L; Babinszky S; Watson PH
    Biopreserv Biobank; 2015 Oct; 13(5):356-62. PubMed ID: 26418967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Academic Biobank Value and Sustainability Through an Outputs Focus.
    Rush A; Catchpoole DR; Ling R; Searles A; Watson PH; Byrne JA
    Value Health; 2020 Aug; 23(8):1072-1078. PubMed ID: 32828220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial stability in biobanking: unique challenges for disease-focused foundations and patient advocacy organizations.
    Bromley RL
    Biopreserv Biobank; 2014 Oct; 12(5):294-9. PubMed ID: 25313427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nottingham Health Science Biobank: a sustainable bioresource.
    Matharoo-Ball B; Thomson BJ
    Biopreserv Biobank; 2014 Oct; 12(5):312-6. PubMed ID: 25340939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taiwan Biobank: a project aiming to aid Taiwan's transition into a biomedical island.
    Fan CT; Lin JC; Lee CH
    Pharmacogenomics; 2008 Feb; 9(2):235-46. PubMed ID: 18370851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Biobanks Are Assessing and Measuring Their Financial Sustainability.
    Brown T; Kelly DD; Vercauteren SM; Wilson WH; Werner A
    Biopreserv Biobank; 2017 Feb; 15(1):65-71. PubMed ID: 27869475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biobanking 3.0: evidence based and customer focused biobanking.
    Simeon-Dubach D; Watson P
    Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.
    Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A
    Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding the Path to Biobank Sustainability Through Sound Business Planning.
    Henderson M; Simeon-Dubach D; Albert M
    Biopreserv Biobank; 2015 Dec; 13(6):385-6. PubMed ID: 26697906
    [No Abstract]   [Full Text] [Related]  

  • 17. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank.
    Vaught J; Rogers J; Carolin T; Compton C
    J Natl Cancer Inst Monogr; 2011; 2011(42):24-31. PubMed ID: 21672892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for biobank sustainability.
    Watson PH; Nussbeck SY; Carter C; O'Donoghue S; Cheah S; Matzke LA; Barnes RO; Bartlett J; Carpenter J; Grizzle WE; Johnston RN; Mes-Masson AM; Murphy L; Sexton K; Shepherd L; Simeon-Dubach D; Zeps N; Schacter B
    Biopreserv Biobank; 2014 Feb; 12(1):60-8. PubMed ID: 24620771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Business Planning for a Campus-Wide Biobank.
    Tarling TE; Lasser F; Carter C; Matzke LA; Dhugga G; Arora N; Dee S; LeBlanc J; Babinsky S; O'Donoghue S; Cheah S; Watson P; Vercauteren SM
    Biopreserv Biobank; 2017 Feb; 15(1):37-45. PubMed ID: 28151006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.